This was the largest study of its kind on GLP-1s in patients with cardiovascular disease, and it found that semaglutide could have cardiovascular benefits beyond its weight-loss effects
Dysfunction of glutamatergic neurotransmission is a core feature of stress-related disorders, including MDD [27,28,29]
Systolic (SBP) and diastolic blood pressure (DBP) were also consistently reduced by incretin-based drugs, ranging from 3.1 and 0.57 mmHg with liraglutide 3.0 mg to 9.2 and 5.1 mmHg with retatrutide, respectively
The direct effect of GLP-1 receptor activation on follicle cycling is still being investigated
10.2337/db14-1706 54
Briefly, super-resolution image stacks were gain-normalized, binned by 2 with Fourier cropping, and corrected for beam-induced motion using MotionCor2 46